Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Mol Psychiatry. 2013 Aug 20;19(6):717–723. doi: 10.1038/mp.2013.99

Table 2.

Results from each GWAS phase where at least one result generated p<10−6. AA=African American; EA=European American; RAF=reference allele frequency; RSQ=imputation quality; genome wide significant results shown in bold, italicized font and underlined; p-values < 1×10−6. underlined; SNPs in bold were genotyped in phase 1; Meta=meta-analysis results.

Case-Control Analysis Phase 1 Phase 2 Phase 3
Chr SNP Gene AA P EA P Meta Phase 1 RAF AA RAF EA RSQ AA RSQ EA AA P EA P RAF AA RAF EA RSQ AA RSQ EA AA P EA P RAF AA RAF EA Meta AA P Meta EA P Meta All P
1 rs200085570 NA 1.37E-01 2.89E-09 3.52E-06 0.97 0.96 0.71 0.83 7.32E-01 3.28E-01 0.96 0.96 0.76 0.88 NA NA NA NA NA NA NA
1 rs6677435 NA 8.75E-01 2.18E-07 7.53E-04 0.99 0.96 0.77 0.84 8.36E-01 1.41E-01 0.98 0.96 0.980 0.98 5.05E-01 9.29E-01 0.02 0.05 8.61E-01 8.82E-06 3.23E-03
1 rs116439821 LGR6 2.71E-07 NA * 0.96 1.00 0.91 0.91 5.67E-01 NA 0.96 1.00 0.94 0.00 4.53E-01 NA 0.04 1.00 1.55E-05 NA 1.55E-05
2 rs72840936 STEAP3 5.34E-01 8.43E-07 9.29E-03 0.98 0.96 0.87 0.96 6.29E-01 1.71E-01 0.98 0.96 0.90 0.99 9.84E-01 3.41E-01 0.01 0.04 4.61E-01 3.19E-06 7.22E-03
3 rs111325002 NA 1.04E-07 NA * 0.97 1.00 0.93 0.17 4.41E-01 NA 0.98 1.00 0.96 0.82 NA NA NA NA 3.70E-07 NA 3.70E-07
4 rs4861386 UCHL1 4.14E-01 8.35E-07 1.96E-04 0.51 0.41 0.96 0.99 4.18E-01 4.51E-01 0.54 0.43 0.96 0.96 8.35E-01 7.70E-01 0.51 0.41 3.32E-01 1.61E-04 9.34E-04
4 rs1757939 SCLT1 7.88E-07 7.22E-01 2.88E-04 0.41 0.43 0.95 0.93 4.02E-01 9.64E-01 0.40 0.42 0.99 0.99 3.09E-01 9.45E-01 0.38 0.42 2.90E-05 8.05E-01 4.36E-03
4 rs4129566 NA 4.26E-07 8.11E-01 4.29E-05 0.90 0.86 0.98 0.99 2.05E-01 8.16E-01 0.89 0.86 0.99 0.94 7.13E-01 1.92E-04 0.90 0.86 2.89E-06 5.49E-02 2.50E-06
4 rs11944332 RANP6 4.11E-07 8.03E-01 4.08E-05 0.90 0.86 0.98 0.99 2.08E-01 8.57E-01 0.89 0.86 0.99 0.94 9.19E-01 2.17E-04 0.91 0.86 1.86E-06 5.95E-02 2.06E-06
6 rs6912117 PXT1 4.54E-02 5.06E-07 2.51E-06 0.69 0.79 0.97 0.99 9.47E-01 3.96E-01 0.71 0.80 0.94 0.98 6.52E-01 8.54E-01 0.69 0.79 7.16E-02 1.60E-03 4.95E-04
6 rs59955083 PXT1 4.47E-02 5.67E-07 2.62E-06 0.69 0.79 0.97 0.99 9.29E-01 3.59E-01 0.71 0.80 0.94 0.99 NA NA NA NA 8.09E-02 7.95E-04 3.86E-04
8 rs75686122 RIMS2 5.24E-07 4.98E-01 1.45E-05 0.96 0.91 0.97 0.97 7.68E-01 4.70E-01 0.97 0.91 0.95 1.00 3.03E-01 5.78E-01 0.02 0.08 2.83E-06 5.21E-01 1.30E-04
10 rs34831910 NA 4.51E-01 6.78E-07 1.16E-02 0.98 0.87 0.96 0.98 8.57E-01 3.40E-01 0.98 0.85 0.95 1.00 3.47E-01 3.93E-01 0.04 0.13 6.86E-01 9.13E-03 1.31E-01
10 rs7899919 NA 5.04E-01 3.30E-07 7.41E-03 0.98 0.87 0.97 1.00 6.67E-01 2.36E-01 0.98 0.86 0.96 0.98 8.78E-01 3.71E-01 0.04 0.13 4.25E-01 8.52E-04 8.36E-02
10 rs9664175 NA 4.78E-01 1.98E-07 6.82E-03 0.98 0.87 0.96 1.00 6.84E-01 2.51E-01 0.98 0.86 0.96 0.98 3.94E-01 2.86E-01 0.03 0.13 2.93E-01 4.72E-04 9.74E-02
10 rs7086629 CHST3 7.40E-07 NA * 0.96 1.00 0.99 NA 6.04E-01 NA 0.96 1.00 0.99 NA 7.32E-01 9.74E-01 0.96 1.00 5.11E-05 NA 1.93E-04
17 rs2005290 OR3A2/OR3A1 1.97E-03 1.41E-05 2.86E-07 0.15 0.06 0.79 0.66 4.43E-01 5.98E-02 0.14 0.04 0.80 0.65 6.16E-01 1.42E-01 0.35 0.14 1.49E-02 1.96E-06 4.47E-07
17 rs114903983 HSF5 4.10E-07 NA * 0.94 1.00 0.99 NA 7.31E-01 NA 0.96 1.00 0.94 NA 3.00E-01 7.90E-01 0.95 1.00 1.56E-04 NA 3.26E-04
17 rs116087723 MTMR4 2.63E-07 NA * 0.94 1.00 1.00 NA 6.16E-01 NA 0.96 1.00 0.96 NA 1.34E-01 7.90E-01 0.06 0.00 2.92E-04 NA 5.68E-04
18 rs79794368 MYL12A 6.81E-07 NA * 0.96 1.00 0.93 NA 4.16E-01 NA 0.96 1.00 0.88 NA 1.20E-01 NA 0.05 0.00 1.48E-05 NA 1.48E-05
18 rs13381416 MYL12A 7.70E-07 NA * 0.96 1.00 0.93 NA 4.13E-01 NA 0.96 1.00 0.88 NA 6.49E-02 NA 0.95 1.00 1.06E-05 NA 1.06E-05
18 rs61751192 MYL12A 9.12E-07 NA * 0.96 1.00 0.93 NA 4.12E-01 NA 0.96 1.00 0.89 NA 1.08E-01 NA 0.05 0.00 1.73E-05 NA 1.73E-05
18 rs12956327 FAM69C 5.66E-07 7.84E-01 1.94E-04 0.93 0.81 0.86 0.93 8.50E-01 1.65E-01 0.93 0.81 0.80 0.93 9.26E-01 9.27E-01 0.06 0.17 1.57E-05 3.52E-01 1.33E-02
Symptom count
10 rs2629540 FAM53B 3.78E-06 4.97E-03 7.64E-08 0.93 0.75 0.94 0.95 6.02E-02 9.44E-02 0.94 0.74 0.95 0.96 4.57E-01 4.87E-01 0.94 0.77 1.38E-06 2.62E-03 4.28E-08
12 rs150954431 NCOR2 5.36E-01 1.19E-09 1.23E-03 0.99 0.97 0.63 0.65 5.84E-01 1.47E-01 0.99 0.97 0.61 0.59 3.32E-01 1.83E-01 1.00 0.98 5.66E-01 5.35E-07 9.41E-04
16 rs4782559 CDH13 9.31E-07 8.11E-02 7.54E-07 0.22 0.46 0.90 0.97 7.90E-01 9.62E-01 0.25 0.47 0.83 0.93 NA NA 1.00 1.00 1.82E-05 2.77E-01 1.54E-04
Cocaine induced Paranoia
10 rs2456778 CDK1 4.86E-08 5.02E-02 4.26E-08 0.25 0.26 0.98 0.98 NA NA NA NA NA NA 1.58E-01 6.36E-01 0.23 0.23 4.77E-06 5.53E-02 2.586E-06